🍁 Canadian GLP-1 news & analysis
GLP-1 Pricing Blog
Generic timelines, pharmacy pricing trends, insurance guides, and news that affects what Canadians pay for GLP-1 medications.
Plosbrio and Poviztra in Canada: Novo Nordisk’s Lower-Price Semaglutide, Explained
Plosbrio (identical to Ozempic) and Poviztra (identical to Wegovy) are approved in Canada. Compare names, pricing strategy, and availability status.
Generic Semaglutide in Canada Delayed: Updated 2026 Timeline, Rejections, and Expected Prices
Generic semaglutide in Canada faces delays: Health Canada rejections, revised timelines to Q3 2026, and new entrants. Updated Feb 2026 with expected CAD $40-78/month pricing.
Zepbound Now Available in Canada: Price, Dosages, and How It Compares
Zepbound (tirzepatide) is now available in Canada. See current pricing by dosage, how it compares to Mounjaro, Wegovy, and Ozempic, and the Eli Lilly patient support program.
Eli Lilly Cuts Mounjaro and Zepbound Prices in Canada: New 2026 Pricing
Eli Lilly reduced Canadian list prices for Mounjaro and Zepbound effective Dec 29, 2025. See the new per-dose pricing in CAD and how it compares.
Looking for current pharmacy prices?
Compare GLP-1 prices across Canada